ResearcherAga Khan University HospitalActive in the last 2 years
SM Adnan Ali
Matched on OpenAlex author ID A5022331845. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 2
2024: 2 papers · 2025: 1 paper
Papers 3
- TP53 c.730G > A pathogenic variant as a plausible candidate biomarker in pancreatic ductal adenocarcinoma patients from Karachi, pakistan: a retrospective coho… Co-author DOI 10.1186/s12885-025-15057-0↗
- Proteomic biomarkers profiling in Pakistani pancreatic ductal adenocarcinoma population: a retrospective cohort study. Last author DOI 10.1080/17520363.2024.2416888↗
- Significant association of miRNA 34a with BRCA1 expression in pancreatic ductal adenocarcinoma: an insight on miRNA regulatory pathways in the Pakistani popula… Last author DOI 10.1186/s12885-024-13259-6↗
Closest collaborators
The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Saleema Mehboob Ali · 3 shared papers, 2024–2025 · strength 0.82
- Paper TP53 c.730G > A pathogenic variant as a plausible candidate biomarker in pancreatic ductal adenocarcinoma patients from… DOI 10.1186/s12885-025-15057-0↗
- Paper Proteomic biomarkers profiling in Pakistani pancreatic ductal adenocarcinoma population: a retrospective cohort study. DOI 10.1080/17520363.2024.2416888↗
- Paper Significant association of miRNA 34a with BRCA1 expression in pancreatic ductal adenocarcinoma: an insight on miRNA reg… DOI 10.1186/s12885-024-13259-6↗
- Hasnain Ahmed Farooqui · 2 shared papers, 2024–2025 · strength 0.54
- Paper TP53 c.730G > A pathogenic variant as a plausible candidate biomarker in pancreatic ductal adenocarcinoma patients from… DOI 10.1186/s12885-025-15057-0↗
- Paper Significant association of miRNA 34a with BRCA1 expression in pancreatic ductal adenocarcinoma: an insight on miRNA reg… DOI 10.1186/s12885-024-13259-6↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.